AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
GlaxoSmithKline And Roche Agree To Codevelop Ibandronate.
2002 JAN 10 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline, Plc, (GSK) and Roche have signed an agreement to codevelop and copromote ibandronate, currently in Phase III clinical development, for the treatment and prevention of postmenopausal osteoporosis.
Given the promising clinical trial results, Roche will be able to take full advantage of the potential of this exciting and promising medicine by collaborating with a strong development and marketing partner. Combining Roche and GSK's development, marketing and sales capabilities will provide the maximum added value for patients and prescribers.
"Roche and Glaxo were among the first companies to adopt copromotion in the 1980s with the launch of Zantac in the U.S. We have demonstrated how we can work together successfully," said William M. Burns, head of Roche's pharmaceutical division.
Under the terms of the agreement, Roche and GSK will share the future development and registration costs for the product and Roche will receive certain milestone payments from GSK. ...
- Boniva makers slam P&G for unethical marketing; GSK, Roche say marketer told...
- Magazine article from: Advertising Age Neff, Jack June 12, 2006 700+ words
...Boniva's advance against Actonel. Roche and GSK are seeking an injunction to stop...We stand by our complaint against Roche and GSK,'' said a spokesman for P&...spokesman said. "In response to Roche/GSK's argument that the survey is...
- P&G/Sanofi file suit against Roche/GSK.(Procter & Gamble Pharmaceuticals;...
- Newspaper article from: Pharma Marketletter January 16, 2006 700+ words
...of New York. This alleges that Roche and GSK engaged in false and misleading...spinal fractures at three years. Roche and GSK defend their promotion For their parts, Roche and GSK have defended their promotion of...
- India asks Roche, GSK to build up bird flu drug stock.
- Newspaper article from: Economic Times (New Delhi, India) December 12, 2005 700+ words
...has asked GlaxoSmithKline and Roche to build up the stock of Oseltamivir...heads of the Indian arms of MNCs Roche and GlaxoSmithKline. According...Kalayanasundram, managing director, GSK India, said: "The government...the government's request." Roche's flu drug -- Tamiflu (generic...
- Roche, GSK urge employers to stockpile flu drugs.
- News wire article from: The America's Intelligence Wire September 26, 2008 700+ words
...s recommendations state. Roche followed that lead by starting...own earlier this month. GSK is in negotiations with numerous...have reserved drugs under Roche's program and deals are...midsize to Fortune 100 firms. GSK is offering employers the...
- Roche/GSK's Bonviva at a monthly dose.(Roche and GlaxoSmithKline report )(Brief...
- Newspaper article from: Pharma Marketletter January 19, 2004 700+ words
Switzerland's Roche and UK-headquartered GlaxoSmithKline have revealed that MOBILE, the...reconstruction, will be handed to regulators. They also suggest that, on GSK's earlier guidance that the drug is "a good bet," it has a peak sales...
- Manufacturing Chemist: Roche, GSK, in global pact to develop and promote...
- News wire article from: Chemical Business Newsbase March 11, 2002 700+ words
Roche and GSK have forged a global pact to co-develop and promote ibandronate, a post-menopausal osteoporosis treatment from GSK. Ibandronate is in Phase III clinical development. The treatment, which...
- GSK licenses OTC orlistat from Roche; companies settle carvedilol...
- Newspaper article from: Pharma Marketletter February 26, 2007 700+ words
...agreements remain undisclosed though, as part of the licensing agreement, Roche will receive an upfront payment from GSK; this will be offset by a payment made by Roche to GSK as a part of the settlement agreement.
- Roche sells OTC business to Bayer for 3.6B SwFr and non-RX orlistat to...
- Newspaper article from: Pharma Marketletter July 26, 2004 700+ words
...Consumer Care Division. GSK deal for USA worth $100M...milestones and royalties Roche has also out-licensed...milestones and royalties. Roche will retain all prescription...formulations outside the USA. Roche and GSK have already begun working...
- Swine flu is sweet pill for Roche and GSK.
- News wire article from: Chemical Business Newsbase May 5, 2009 700+ words
GlaxoSmithKline's (GSK) Relenza and Roche's Tamiflu, two of the...supply of the drug. Though GSK has sent 100,000 packs of Relenza to Mexico and Roche claims to have 3 M packages...supply. From 27 Apr 2009, Roche and GSK are coordinating with...
- Healthcare: Roche and GSK close in on global Bonviva PR hire.(Brief Article)
- Newspaper article from: PR Week (UK) November 19, 2004 700+ words
...were for a once-daily formulation - Roche and GSK do not want to launch the product...established Fosamax. Basel-based Roche international communications manager...that an appointment was imminent. GSK PR director Tina Phelan is also involved...
Source: HighBeam Research, GlaxoSmithKline And Roche Agree To Codevelop Ibandronate.